Categories AlphaGraphs, Earnings, Technology

DOCU Earnings: DocuSign Q3 2024 revenue up 9%; profit beats estimates

eSignature service provider DocuSign, Inc. (NASDAQ: DOCU) reported higher revenues and better-than-expected adjusted earnings for the third quarter of 2024. The company also provided guidance for the fourth quarter and fiscal 2024.

DocuSign Q3 2023 earnings infographic

DocuSign generated total revenues of $700.4 million in the October quarter, compared to $645.5 million in the same period last year. Subscription revenue increased 9% year-over-year during the three months, while professional service revenue declined 16%.

Adjusted earnings came in at $0.79 per share in Q3, vs. $0.57 per share in the year-ago quarter. Third-quarter net profit was $38.8 million or $0.19 per share, compared to a loss of $29.9 million or $0.15 per share in the corresponding period of 2023.

Prior Performance

  • DocuSign Q3 2023 earnings infographic

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Home Depot (HD) Q4 2023 Earnings: Key financials and quarterly highlights

Home Depot (NYSE: HD) reported fourth quarter 2023 earnings results today. Sales were $34.8 billion, down 2.9% from the same quarter a year ago. Comparable sales decreased 3.5%.  Net earnings were $2.8

Nvidia (NVDA) is set to report Q4 2024 results. Here is what to expect

Nvidia Corporation (NASDAQ: NVDA) has emerged as the frontrunner in providing cutting-edge solutions to enterprises for ramping up their generative AI deployments. The chipmaker is thriving on the rapid transition

Hasbro vs. Mattel: Here’s how these toymakers fared in Q4 2023

Leading toymakers Hasbro, Inc. (NASDAQ: HAS) and Mattel, Inc. (NASDAQ: MAT) reported their fourth quarter 2023 earnings results this month. Both companies performed differently, with Hasbro coming out of a

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top